The US medical devices industry saw a drop of 14.6% in overall deal activity during October 2020, when compared with the last 12-month average, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the code below into your website to display the chart.

A total of 70 deals worth $5.64bn were announced in October 2020, compared to the 12-month average of 82 deals.

Venture financing was the leading category in the month in terms of volume with 40 deals which accounted for 57.1% of all deals.

In second place was M&A with 18 deals, followed by private equity with 12 transactions, respectively accounting for 25.7% and 17.1% of overall deal activity in the country’s medical devices industry during the month.

In terms of value of deals, M&A was the leading deal category in the US medical devices industry with total deals worth $3.75bn, while private equity and venture financing deals totalled $1.32bn and $576.77m, respectively.

US medical devices industry deals in October 2020: Top deals

The top five medical devices industry deals accounted for 82.05% of the overall value during October 2020.

The combined value of the top five medical devices deals stood at $4.63bn, against the overall value of $5.64bn recorded for the month.

The top five medical devices industry deals of October 2020 tracked by GlobalData were:

1) Exact Sciences‘ $2.15bn acquisition of Thrive Earlier Detection

2) The $869.2m private equity deal with Exact Sciences by Casdin Capital and Rock Springs Capital Management

3) Steris’ $850m acquisition of Key Surgical

4) The $525m acquisition of Z-Medica by Teleflex

5) ClearBridge Investments, Coatue Management, First Light Asset Management, Highland Capital Partners, Millennium Management, Neuberger Berman Wealth Management, Orbimed Advisors, TPG Sixth Street Partners and T Rowe Price Associates’ private equity deal with Caris Life Sciences for $235m.

Verdict deals analysis methodology

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.

GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.

More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.